Journey Medical (DERM)

• Market cap: $280M
• 1 day: -1.64%
• 5 days: 0.6%
• 1 month: 18.12%
• 3 months: -6.56%
• 6 months: 17.79%
• Year to date: 12.89%
• 1 year: 57.2%
• 5 years: -11.47%
• 10 years: -11.47%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

Employees: 41